Sensus Healthcare (SRTS) Competitors

$6.14
+0.84 (+15.85%)
(As of 05/15/2024 ET)

SRTS vs. MGRM, PDEX, HSAQ, SEPA, NVNO, ICCM, AMIX, LUCD, CTSO, and NSPR

Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Monogram Orthopaedics (MGRM), Pro-Dex (PDEX), Health Sciences Acquisitions Co. 2 (HSAQ), SEP Acquisition (SEPA), enVVeno Medical (NVNO), IceCure Medical (ICCM), Autonomix Medical (AMIX), Lucid Diagnostics (LUCD), Cytosorbents (CTSO), and InspireMD (NSPR). These companies are all part of the "surgical & medical instruments" industry.

Sensus Healthcare vs.

Sensus Healthcare (NASDAQ:SRTS) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, community ranking, dividends, valuation and earnings.

Sensus Healthcare received 178 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users.

CompanyUnderperformOutperform
Sensus HealthcareOutperform Votes
178
67.94%
Underperform Votes
84
32.06%
Monogram OrthopaedicsN/AN/A

Sensus Healthcare has a net margin of 14.70% compared to Monogram Orthopaedics' net margin of 0.00%. Sensus Healthcare's return on equity of 9.76% beat Monogram Orthopaedics' return on equity.

Company Net Margins Return on Equity Return on Assets
Sensus Healthcare14.70% 9.76% 8.72%
Monogram Orthopaedics N/A -143.70%-83.17%

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are owned by institutional investors. 11.1% of Sensus Healthcare shares are owned by insiders. Comparatively, 32.1% of Monogram Orthopaedics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Sensus Healthcare presently has a consensus target price of $10.00, suggesting a potential upside of 62.87%. Given Sensus Healthcare's higher probable upside, equities research analysts plainly believe Sensus Healthcare is more favorable than Monogram Orthopaedics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sensus Healthcare
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Monogram Orthopaedics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Sensus Healthcare had 21 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 28 mentions for Sensus Healthcare and 7 mentions for Monogram Orthopaedics. Monogram Orthopaedics' average media sentiment score of 0.76 beat Sensus Healthcare's score of 0.67 indicating that Monogram Orthopaedics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sensus Healthcare
5 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Monogram Orthopaedics
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Sensus Healthcare has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sensus Healthcare$24.41M4.12$490K$0.2921.17
Monogram Orthopaedics$370K176.10-$13.74M-$0.79-2.61

Summary

Sensus Healthcare beats Monogram Orthopaedics on 12 of the 15 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTS vs. The Competition

MetricSensus HealthcareSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$100.64M$3.91B$5.10B$7.99B
Dividend YieldN/A2.01%36.92%3.93%
P/E Ratio21.1716.90186.5618.76
Price / Sales4.1272.062,379.7379.45
Price / Cash93.5146.9335.5831.18
Price / Book1.974.675.464.47
Net Income$490,000.00$4.48M$105.01M$217.31M
7 Day Performance61.15%1.87%1.43%1.57%
1 Month Performance91.88%3.19%3.73%5.04%
1 Year Performance111.36%18.87%7.94%12.01%

Sensus Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGRM
Monogram Orthopaedics
0.7533 of 5 stars
$1.96
-3.9%
N/AN/A$62.00M$370,000.00-2.4828
PDEX
Pro-Dex
0 of 5 stars
$17.90
+0.7%
N/A+24.0%$61.22M$46.09M30.86145
HSAQ
Health Sciences Acquisitions Co. 2
0 of 5 stars
$5.24
+2.7%
N/A-72.4%$58.75MN/A0.004
SEPA
SEP Acquisition
0 of 5 stars
$11.22
+10.0%
N/A+3.0%$65.19MN/A0.00N/AGap Down
NVNO
enVVeno Medical
0.2358 of 5 stars
$5.06
-0.6%
N/A+21.7%$67.40MN/A-2.6419Positive News
Gap Up
ICCM
IceCure Medical
2.6059 of 5 stars
$1.21
+1.7%
$2.95
+143.8%
-3.2%$55.20M$3.23M-3.6771Short Interest ↓
High Trading Volume
AMIX
Autonomix Medical
0 of 5 stars
$2.81
-10.8%
N/AN/A$52.80MN/A0.001Positive News
LUCD
Lucid Diagnostics
1.8846 of 5 stars
$1.03
-1.0%
$2.75
+167.0%
-39.7%$51.27M$2.43M-0.8170Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
High Trading Volume
CTSO
Cytosorbents
1.0189 of 5 stars
$0.93
flat
$2.50
+168.2%
-74.6%$50.63M$36.35M-1.46186Earnings Report
Analyst Forecast
News Coverage
NSPR
InspireMD
1.5965 of 5 stars
$2.10
-0.9%
$4.85
+131.0%
+25.0%$49.61M$6.21M-1.9465Earnings Report
News Coverage

Related Companies and Tools

This page (NASDAQ:SRTS) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners